18F-FAPI-PET/CT

18F-labeled fibroblast activation protein inhibitor positron emission tomography/computed tomography imaging tracer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 18F-FAPI-PET/CT, covering 2025-06-10 to 2025-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Rationale and Trial Design of PFB-03 Study: Diagnostic Performance and Clinical Application of 18F-FAPI-PET/CT for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients After Neoadjuvant Therapy

See pricing